Early Survival of Comatose Patients after Severe Traumatic Brain Injury with the Dual Cannabinoid CB1/CB2 Receptor Agonist KN38-7271: A Randomized, Double-Blind, Placebo-Controlled Phase II Trial

Receptor Agonist ◽

Phase Ii Trial ◽

Cb2 Receptor ◽

Double Blind ◽

Double Blind Placebo ◽

Early Survival

A phase II, randomised, double-blind, placebo-controlled, dose-finding, safety and tolerability trial of XY2405 as a treatment for traumatic brain injury

http://isrctn.org/> ◽

10.1186/isrctn23625128 ◽

2012 ◽

Author(s):

Ian Roberts

Keyword(s):

Traumatic Brain Injury ◽

Brain Injury ◽

Phase Ii ◽

Dose Finding ◽

Double Blind ◽

Subacute methylphenidate treatment for moderate to moderately severe traumatic brain injury: A preliminary double-blind placebo-controlled study

Archives of Physical Medicine and Rehabilitation ◽

10.1016/s0003-9993(96)90291-9 ◽

1996 ◽

Vol 77 (6) ◽

pp. 536-540 ◽

Cited By ~ 139

Author(s):

Patrict M. Plenger ◽

C.Edward Dixon ◽

Rosario M. Castillo ◽

Ralph F. Frankowski ◽

Stuart A. Yablon ◽

...

Keyword(s):

Traumatic Brain Injury ◽

Brain Injury ◽

Controlled Study ◽

Double Blind ◽

Effects of atorvastatin on brain contusion volume and functional outcome of patients with moderate and severe traumatic brain injury; a randomized double-blind placebo-controlled clinical trial

Journal of Clinical Neuroscience ◽

10.1016/j.jocn.2017.06.010 ◽

2017 ◽

Vol 44 ◽

pp. 143-147 ◽

Cited By ~ 7

Author(s):

Gholam Reza Farzanegan ◽

Nima Derakhshan ◽

Hosseinali Khalili ◽

Fariborz Ghaffarpasand ◽

Shahram Paydar

Keyword(s):

Clinical Trial ◽

Traumatic Brain Injury ◽

Brain Injury ◽

Functional Outcome ◽

Controlled Clinical Trial ◽

Double Blind ◽

Brain Contusion ◽

Faculty Opinions recommendation of Efficacy of methylphenidate in the rehabilitation of attention following traumatic brain injury: a randomised, crossover, double blind, placebo controlled inpatient trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1157721.617938 ◽

2009 ◽

Author(s):

Philippe Azouvi

Keyword(s):

Traumatic Brain Injury ◽

Brain Injury ◽

Double Blind ◽

A European Organisation for Research and Treatment of Cancer randomized, double-blind, placebo-controlled, multicentre phase II trial of anastrozole in combination with gefitinib or placebo in hormone receptor-positive advanced breast cancer (NCT00066378)

European Journal of Cancer ◽

10.1016/j.ejca.2015.10.012 ◽

2016 ◽

Vol 53 ◽

pp. 144-154 ◽

Cited By ~ 19

Author(s):

Konstantinos Tryfonidis ◽

Gul Basaran ◽

Jan Bogaerts ◽

Marc Debled ◽

Luc Dirix ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Hormone Receptor ◽

Phase Ii Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Multicentre Phase ◽

European Organisation ◽

Hormone Receptor Positive

Study Protocol for a Randomized, Double-Blind, Placebo-Controlled, Phase-II Trial: AdrenoMedullin for Ischemic Stroke Study

Journal of Stroke and Cerebrovascular Diseases ◽

10.1016/j.jstrokecerebrovasdis.2021.105761 ◽

2021 ◽

Vol 30 (6) ◽

pp. 105761

Author(s):

Takeshi Yoshimoto ◽

Satoshi Saito ◽

Katsuhiro Omae ◽

Yorito Hattori ◽

Kazuki Fukuma ◽

...

Keyword(s):

Ischemic Stroke ◽

Phase Ii ◽

Study Protocol ◽

Phase Ii Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Stroke Study

Aprepitant in Anti-histamine-refractory Chronic Nodular Prurigo: A Multicentre, Randomized, Double-blind, Placebo-controlled, Cross-over, Phase-II trial (APREPRU)

Acta Dermato Venereologica ◽

10.2340/00015555-3120 ◽

2019 ◽

Vol 99 (4) ◽

pp. 379-385 ◽

Cited By ~ 19

Author(s):

A Tsianakas ◽

C Zeidler ◽

C Riepe ◽

M Borowski ◽

C Forner ◽

...

Keyword(s):

Phase Ii ◽

Phase Ii Trial ◽

Double Blind ◽

CRASH-3 - tranexamic acid for the treatment of significant traumatic brain injury: study protocol for an international randomized, double-blind, placebo-controlled trial

Trials ◽

10.1186/1745-6215-13-87 ◽

2012 ◽

Vol 13 (1) ◽

Cited By ~ 114

Author(s):

Yashbir Dewan ◽

Edward O Komolafe ◽

Jorge H Mejía-Mantilla ◽

Pablo Perel ◽

Ian Roberts ◽

...

Keyword(s):

Traumatic Brain Injury ◽

Brain Injury ◽

Tranexamic Acid ◽

Study Protocol ◽

Controlled Trial ◽

Double Blind ◽

Recombinant human erythropoietin improves functional recovery in patients with severe traumatic brain injury: A randomized, double blind and controlled clinical trial

Clinical Neurology and Neurosurgery ◽

10.1016/j.clineuro.2016.09.001 ◽

2016 ◽

Vol 150 ◽

pp. 80-83 ◽

Cited By ~ 24

Author(s):

Zhong-min Li ◽

Yi-lei Xiao ◽

Jian-xin Zhu ◽

Feng-yang Geng ◽

Chuan-jun Guo ◽

...

Keyword(s):

Clinical Trial ◽

Traumatic Brain Injury ◽

Brain Injury ◽

Functional Recovery ◽

Recombinant Human Erythropoietin ◽

Controlled Clinical Trial ◽

Double Blind ◽

Human Erythropoietin

Abstract P2-08-19: Exploratory biomarker analyses of FAIRLANE, a double-blind placebo (PBO)-controlled randomized phase II trial of neoadjuvant ipatasertib (IPAT) + paclitaxel (PAC) for early triple-negative breast cancer (TNBC)

10.1158/1538-7445.sabcs18-p2-08-19 ◽

2019 ◽

Author(s):

MJ Wongchenko ◽

M Oliveira ◽

C Saura ◽

P Nuciforo ◽

I Calvo ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Triple Negative Breast Cancer ◽

Triple Negative ◽

Phase Ii Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Randomized Phase Ii